These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 33301389)

  • 1. Weiss Response to Sengupta et al. (DOI: 10.1089/scd.2020.0095).
    Weiss DJ; Lim SK; Rohde E; Witwer KW; Giebel B
    Stem Cells Dev; 2020 Dec; 29(24):1533-1534. PubMed ID: 33301389
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.
    Lim SK; Giebel B; Weiss DJ; Witwer KW; Rohde E
    Stem Cells Dev; 2020 Jul; 29(14):877-878. PubMed ID: 32520641
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to Lim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19".
    Sengupta V; Sengupta S; Lazo A; Hicok KC; Moseley T
    Stem Cells Dev; 2020 Jul; 29(14):879-881. PubMed ID: 32520639
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
    Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
    Akkoc T
    Adv Exp Med Biol; 2020; 1298():167-176. PubMed ID: 32648245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
    Wang J; Zou W; Liu J
    Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
    O'Driscoll L
    Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects.
    Chen X; Shan Y; Wen Y; Sun J; Du H
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32422152
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019.
    Ji F; Li L; Li Z; Jin Y; Liu W
    Stem Cells Transl Med; 2020 Jul; 9(7):813-814. PubMed ID: 32320535
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Jan-Niclas Mumm, Andreas Osterman, Michael Ruzicka, et al. Urinary Frequency as a Possible Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.05.013: Severe Involvement of the Urinary Tract During COVID-19 Infection.
    Luciani LG; Gallo F; Malossini G
    Eur Urol; 2020 Sep; 78(3):e129-e130. PubMed ID: 32591102
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev
    Spinelli FR; Ceccarelli F; Di Franco M; Conti F
    Ann Rheum Dis; 2021 Feb; 80(2):e20. PubMed ID: 32345618
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to Wang et al., Virtual Reality as a Bridge in Palliative Care during COVID-19 (DOI: 10.1089/jpm.2020.0212).
    Niki K; Okamoto Y; Ueda M
    J Palliat Med; 2020 Jul; 23(7):892-894. PubMed ID: 32393088
    [No Abstract]   [Full Text] [Related]  

  • 17. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
    Rossi F; Tortora C; Argenziano M; Di Paola A; Punzo F
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
    Sahu KK; Siddiqui AD; Cerny J
    Lab Med; 2021 Jan; 52(1):24-35. PubMed ID: 32729620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2.
    Mao XY; Jin WL
    ACS Chem Neurosci; 2020 Sep; 11(17):2489-2491. PubMed ID: 32840109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic.
    Poljak M; Korva M; Knap Gašper N; Fujs Komloš K; Sagadin M; Uršič T; Avšič Županc T; Petrovec M
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32277022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.